ARCH Venture Partners β 2021 Investments
11 investments dated 2021 Β· listed companies and verified rows first Β· show all
Boundless Bio develops precision oncology medicines targeting ecDNA-amplified cancers, specifically creating a new category of ecDNA-directed therapies for patients with oncogenic alterations.
BiotechMedical DevicesLa Jolla, US
Benjamin Cravatt, Ph.D.(Director)Ho Sung Cho, Ph.D.(Director)Carolyn Ng, Ph.D.(Director)Jakob Loven, Ph.D.(Director)Zachary D. Hornby(Executive Officer, Director)Jonathan E. Lim, M.D.(Director)
Board seatKristina BurowΒ· per SEC Form D
PerkinElmer is a scientific instrument and technology company that provides analytical tools and services for research, diagnostics, and life sciences applications.
BiotechDeep TechEnterprise SoftwareHealthtechMedical DevicesWaltham, US
Sylvie Gregoire(Director)Michel Vounatsos(Director)Samuel Chapin(Director)James M. Mock(Executive Officer)Andrew Okun(Executive Officer)Pascale Witz(Director)
Cytrellis develops medical device technologies focused on aesthetic and reconstructive treatments, with expertise spanning dermatology, plastic surgery, and wound healing applications.
BiotechHealthtechMedical DevicesWoburn, US
Rox Anderson, MD(Founder, Medical / Technology Advisor)William G. Austen, Jr. MD(Founder, Medical / Technology Advisor)Doug Levinson, PhD(Founder)Denise Dajles, PhD(President & CEO)John McDonough(Executive Officer, Director)Keith Crandall(Director)
Board seatKeith CrandellΒ· per SEC Form D
Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.
BiotechDigital HealthMedical DevicesCambridge, US
DAVID ARTHUR SCOTT(Executive Officer)WINSTON XIA YAN(Executive Officer)ANNIE HAZLEHURST(Director)FENG ZHANG(Director)
BoardDAVID R. WALT(Director)
Board seatKeith CrandellΒ· per SEC Form D
Xtremity develops thermoformable carbon-reinforced polymer prosthetic socket technology and cost-efficient fabrication processes for individuals with transtibial limb loss and the prosthetists who treat them.
HardwareHealthtechMedical DevicesAspen, US
Miguelangel Sosa(Executive Officer, Director)Amy Hill(Executive Officer)Scott Ward(Executive Officer)Mark Joseph(Founder / Inventor & Product Designer)
Board seatRobert NelsenΒ· per SEC Form D Β· $15M raise Β· filed Jun 2021
La Jolla, US
Board seatRobert NelsenΒ· per SEC Form D Β· $755M raise Β· filed Jan 2021
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
Board seatRobert NelsenΒ· per SEC Form D
BiotechHouston, US
Alice Bexon(Executive Officer)Clifford J. Stocks(Director, Executive Officer)Kamal D. Puri(Executive Officer)Chris Russell(Executive Officer)Russ Hawkinson(Executive Officer)Alan Ginsberg(Director)
Board seatSteven GillisΒ· per SEC Form D Β· $60M raise Β· filed Mar 2021
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
BiotechLongevityMedical DevicesCambridge, US
David Meek(Chief Executive Officer)Brian Riley(President & Chief Technical Officer)Joanne Lager(Chief Medical Officer)Wendy DiCicco(Chief Financial Officer)Adrian Chaisson(Chief of Staff)Daniel S. Lynch(Director)
Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Fan Yu(Director)Maggie Wilderotter(Director)Toni Hoover(Director)Terry Rosen(Director)Richard Klausner(Director)Jeffrey Bluestone(Executive Officer, Director, Promoter)
BiotechCambridge, US
Andrew Ashe(Executive Officer)Burt Adelman(Director)John Evans(Director)Sekar Kathiresan(Executive Officer, Director)Andrew Bellinger(Executive Officer)
BoardAnthony Philippakis(Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.